Effect of pan retinal photocoagulation on the serum levels of vascular endothelial growth factor in diabetic patients

International Ophthalmology

Volumn 31, Issue 4, 2011, Pages 271-275

  Manaviat, Masoud Reza ^a   Rashidi, Maryam ^b   Afkhami Ardekani, Mohammad ^b   Mohiti Ardekani, Javad ^a   Bandala Sanchez, Mariaesther ^c  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Yazd Diabetes Research Center   (Iran)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Pan retinal photocoagulation; Proliferative diabetic retinopathy; Type 2 diabetes; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LASER COAGULATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PAN RETINAL PHOTOCOAGULATION; PATIENT MONITORING; PROTEIN BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; IMMUNOASSAY; LIGHT COAGULATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; YOUNG ADULT;

EID: 80054727285     PISSN: 01655701     EISSN: 15732630     Source Type: Journal    
DOI: 10.1007/s10792-011-9448-6     Document Type: Article

References (22)

1. DR Senger SJ Galli AM Dvorak CA Perruzzi VS Harvey HF Dvorak 1983 Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid Science 219 4587 983 985 6823562 10.1126/science.6823562 1:STN:280:DyaL3s7hvF2mtw%3D%3D
2. PJ Keck SD Hauser G Krivi K Sanzo T Warren J Feder, et al. 1989 Vascular permeability factor, an endothelial cell mitogen related to PDGF Science 246 4935 1309 1312 2479987 10.1126/science.2479987 1:CAS:528:DyaK3cXkslGksLc%3D
3. B Millauer LK Shawver KH Plate W Risau A Ullrich 1994 Glioblastoma growth is inhibited in vivo by a negative dominant Flk-1 mutant Nature 367 576 579 8107827 10.1038/367576a0 1:CAS:528:DyaK2cXhs1Sgt7w%3D
4. ME Cooper D Vranes S Youssef SA Stacker AJ Cox B Rizkalla, et al. 1999 Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes Diabetes 48 11 2229 2239 10535459 10.2337/diabetes.48.11.2229 1:CAS:528:DyaK1MXntVSlsb4%3D
5. LP Aiello 1997 Clinical implications of vascular growth factors in proliferative retinopathies Curr Opin Ophthalmol 8 3 19 31 10168890 10.1097/00055735-199706000-00005 1:STN:280:DyaK2svgtF2hsg%3D%3D
6. H Funatsu H Yamashita H Noma H Mochizuki T Mimura T Ikeda, et al. 2003 Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin Investig Ophthalmol Vis Sci 44 3 1042 10.1167/iovs.02-0374
7. N Chaturvedi AK Sjolie JM Stephenson H Abrahamian M Keipes A Castellarin 1998 Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes Lancet 351 9095 28 31 9433426 10.1016/S0140-6736(97)06209-0 1:CAS:528:DyaK1cXmt12qtw%3D%3D
8. LP Aiello RL Avery PG Arrigg BA Keyt HD Jampel ST Shah, et al. 1994 Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 331 22 1480 1487 7526212 10.1056/NEJM199412013312203 1:STN:280:DyaK2M%2FlvFamsA%3D%3D
9. GYH Lip A Blann 1997 von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 34 2 255 9205537 10.1016/S0008-6363(97)00039-4 1:CAS:528:DyaK2sXktlyitb4%3D
10. PL Lip F Belgore AD Blann MW Hope-Ross JM Gibson GYH Lip 2000 Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment Investig Ophthalmol Vis Sci 41 8 2115 1:STN:280:DC%2BD3czkvV2nsw%3D%3D
11. K Shinoda S Ishida S Kawashima T Wakabayashi T Matsuzaki M Takayama, et al. 1999 Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus Br J Ophthalmol 83 7 834 10381671 10.1136/bjo.83.7.834 1:STN:280:DC%2BD3c%2Fgt1SktA%3D%3D
12. MR Manaviat M Afkhami MR Shoja 2004 Retinopathy and microalbuminuria in type II diabetic patients BMC Ophthalmol 4 9 15228626 10.1186/1471-2415-4-9
13. MR Manaviat M Rashidi M Afkhami-Ardekani 2008 Four years incidence of diabetic retinopathy and effective factors on its progression in type II diabetes Eur J Ophthalmol 18 1521 1522
14. MD Davis MR Fisher RE Gangnon F Barton LM Aiello EY Chew, et al. 1998 Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: early treatment diabetic retinopathy study report #18 Invest Ophthalmol Vis Sci 39 2 233 252 9477980 1:STN:280:DyaK1c7jvVCltQ%3D%3D
15. A Celebiler Cavusoglu S Bilgili A Alaluf A Do an Y lmaz D Aslanca, et al. 2007 Vascular endothelial growth factor level in the serum of diabetic patients with retinopathy Ann Ophthalmol 39 3 205 208 10.1007/s12009-007-0037-2
16. BT Ozturk B Bozkurt H Kerimoglu M Okka U Kamis K Gunduz 2009 Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness Mol Vis 15 1906 1914 19784389 1:CAS:528:DC%2BD1MXht1altrjP
17. AD Meleth E Agron CC Chan GF Reed K Arora G Byrnes, et al. 2005 Serum inflammatory markers in diabetic retinopathy Investig Ophthalmol Vis Sci 46 11 4295 10.1167/iovs.04-1057
18. H Kakizawa M Itoh Y Itoh S Imamura Y Ishiwata T Matsumoto, et al. 2004 The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients Metabolism 53 5 550 555 15131756 10.1016/j.metabol.2003.12.002 1:CAS:528:DC%2BD2cXjtl2mt7Y%3D
19. NJA Webb CJ Watson ISD Roberts MJ Bottomley CA Jones MA Lewis, et al. 1999 Circulating vascular endothelial growth factor is not increased during relapses of steroid-sensitive nephrotic syndrome Kidney Int 55 3 1063 10027945 10.1046/j.1523-1755.1999.0550031063.x 1:STN:280:DyaK1M7lt1agsw%3D%3D
20. K Zorena J Myśliwska M Myśliwiec K Rybarczyk-Kapturska E Malinowska P Wiśniewski K Raczyńska 2010 Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus Hum Hypertens 24 11 755 762 10.1038/jhh.2010.7 1:CAS:528:DC%2BC3cXht1Oqtb3K
21. S Emani B Ramlawi NR Sodha J Li C Bianchi FW Sellke 2009 Increased vascular permeability after cardiopulmonary bypass in patients with diabetes is associated with increased expression of vascular endothelial growth factor and hepatocyte growth factor J Thorac Cardiovasc Surg 138 1 185 191 19577077 10.1016/j.jtcvs.2008.12.024
22. T Deguchi T Hashiguchi S Horinouchi T Uto H Oku K Kimura K Makisumi K Arimura 2009 Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage Diabet Med 26 3 247 252 19317819 10.1111/j.1464-5491.2009.02680.x 1:CAS:528:DC%2BD1MXkvVGqtbc%3D